Simple Summary Colorectal cancer (CRC) is a disease that usually shows no evident
clinical symptoms in the early stages, often leading to late diagnosis. Over the past few …

Cell-free nucleic acids (CFNA) have been reported by several authors in blood, stool, and
urine of patients with colorectal cancer (CRC). These genetic biomarkers can be an …

Colorectal cancer (CRC) is one of the most common cancers worldwide, being the third most
diagnosed in the world and the second deadliest. Solid biopsy provides an essential guide …

Colorectal cancer (CRC) is one of the most common malignancies and is a major cause of
cancer-related deaths worldwide. Thus, there is a clinical need to improve early detection of …

Liquid biopsy has emerged as a promising noninvasive approach for colorectal cancer
(CRC) management. This review focuses on technologies detecting circulating nucleic …

Colorectal cancer (CRC), one of the leading causes of death among cancer patients, is a
heterogeneous disease and is characterized by diversions in multiple molecular pathways …

About 15% of colorectal cancers (CRCs) are diagnosed as advanced, metastatic stage IV, a
patient condition with an average survival of 2.5 years. A precise etiology for sporadic CRC …

Colorectal cancer (CRC) is one of the most prevalent malignancies affecting the
gastrointestinal tract and is ranked third among cancers with the highest incidence and …

Introduction: Screening methods for one of the most frequently diagnosed malignancy,
colorectal cancer (CRC), have limitations. Circulating cell-free nucleic acids (cfNA) hold …

Circulating tumour DNAs and non-coding RNAs present in body fluids have been under
investigation as tools for cancer diagnosis, disease monitoring, and prognosis for many …